Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 421 entries
Sorted by: Best Match Show Resources per page
[On listening and talking].

Kurinikaru sutadi = Clinical study

Nishida A.
PMID: 2634180
Kurinikaru Sutadi. 1989 Jun;10(7):722-4.

No abstract available.

Cite
Nishida A. [On listening and talking]. Kurinikaru Sutadi. 1989;10(7):722-4
Nishida, A. (1989). [On listening and talking]. Kurinikaru sutadi = Clinical study, 10(7), 722-4.
Nishida, A. "[On listening and talking]." Kurinikaru sutadi = Clinical study vol. 10,7 (1989): 722-4.
Nishida A. [On listening and talking]. Kurinikaru Sutadi. 1989 Jun;10(7):722-4. Japanese. PMID: 2634180.
Copy Download .nbib Format: NLM
Pediatric hypervirulent Klebsiella pneumoniae septic arthritis.

Pediatrics international : official journal of the Japan Pediatric Society

Kishibe S, Okubo Y, Morino S, Hirotaki S, Tame T, Aoki K, Ishii Y, Ota N, Shimomura S, Sakakibara H, Terakawa T, Horikoshi Y.
PMID: 27005513
Pediatr Int. 2016 May;58(5):382-385. doi: 10.1111/ped.12806. Epub 2016 Mar 23.

Cases of infection with hypervirulent Klebsiella pneumoniae are gradually increasing in number, and cause life-threatening community-acquired infection even in immunocompetent patients. A 14-year-old boy developed septic hip arthritis due to hypervirulent K. pneumoniae (sequence type 23, serotype K1, magA...

Cite
Kishibe S, Okubo Y, Morino S, et al. Pediatric hypervirulent Klebsiella pneumoniae septic arthritis. Pediatr Int. 2016;58(5):382-385doi: 10.1111/ped.12806.
Kishibe, S., Okubo, Y., Morino, S., Hirotaki, S., Tame, T., Aoki, K., Ishii, Y., Ota, N., Shimomura, S., Sakakibara, H., Terakawa, T., & Horikoshi, Y. (2016). Pediatric hypervirulent Klebsiella pneumoniae septic arthritis. Pediatrics international : official journal of the Japan Pediatric Society, 58(5), 382-385. https://doi.org/10.1111/ped.12806
Kishibe, Shun, et al. "Pediatric hypervirulent Klebsiella pneumoniae septic arthritis." Pediatrics international : official journal of the Japan Pediatric Society vol. 58,5 (2016): 382-385. doi: https://doi.org/10.1111/ped.12806
Kishibe S, Okubo Y, Morino S, Hirotaki S, Tame T, Aoki K, Ishii Y, Ota N, Shimomura S, Sakakibara H, Terakawa T, Horikoshi Y. Pediatric hypervirulent Klebsiella pneumoniae septic arthritis. Pediatr Int. 2016 May;58(5):382-385. doi: 10.1111/ped.12806. Epub 2016 Mar 23. PMID: 27005513.
Copy Download .nbib Format: NLM
Modyfied wedge osteotomy for osteoarthritis of elbow secondary to osteochondritis dissecans in adolecent with multiple epiphyseal dysplasia. A case report.

Journal of orthopaedics

Yoshida T, Kim WC, Oka Y, Nakase M, Nishida A, Wada H, Arai Y, Kubo T.
PMID: 28860685
J Orthop. 2017 Aug 10;14(4):515-519. doi: 10.1016/j.jor.2017.08.011. eCollection 2017 Dec.

Multiple epiphyseal dysplasia (MED) may be complicated by osteochondritis dissecans (OCD), most commonly reported in the knee, but involvement of the elbow is very rare. Optimal treatment for MED-associated elbow OCD and treatment outcome have not been established. This...

Cite
Yoshida T, Kim WC, Oka Y, et al. Modyfied wedge osteotomy for osteoarthritis of elbow secondary to osteochondritis dissecans in adolecent with multiple epiphyseal dysplasia. A case report. J Orthop. 2017;14(4):515-519doi: 10.1016/j.jor.2017.08.011.
Yoshida, T., Kim, W. C., Oka, Y., Nakase, M., Nishida, A., Wada, H., Arai, Y., & Kubo, T. (2017). Modyfied wedge osteotomy for osteoarthritis of elbow secondary to osteochondritis dissecans in adolecent with multiple epiphyseal dysplasia. A case report. Journal of orthopaedics, 14(4), 515-519. https://doi.org/10.1016/j.jor.2017.08.011
Yoshida, Takashi, et al. "Modyfied wedge osteotomy for osteoarthritis of elbow secondary to osteochondritis dissecans in adolecent with multiple epiphyseal dysplasia. A case report." Journal of orthopaedics vol. 14,4 (2017): 515-519. doi: https://doi.org/10.1016/j.jor.2017.08.011
Yoshida T, Kim WC, Oka Y, Nakase M, Nishida A, Wada H, Arai Y, Kubo T. Modyfied wedge osteotomy for osteoarthritis of elbow secondary to osteochondritis dissecans in adolecent with multiple epiphyseal dysplasia. A case report. J Orthop. 2017 Aug 10;14(4):515-519. doi: 10.1016/j.jor.2017.08.011. eCollection 2017 Dec. PMID: 28860685; PMCID: PMC5568871.
Copy Download .nbib Format: NLM
Functional remnant liver assessment predicts liver-related morbidity after hepatic resection in patients with hepatocellular carcinoma.

Hepatology research : the official journal of the Japan Society of Hepatology

Itoh S, Yoshizumi T, Shirabe K, Kimura K, Okabe H, Harimoto N, Ikegami T, Uchiyama H, Nishie A, Maehara Y.
PMID: 27283504
Hepatol Res. 2017 Apr;47(5):398-404. doi: 10.1111/hepr.12761. Epub 2016 Sep 12.

AIM: We aimed to evaluate whether functional assessment of the future remnant liver is a predictor of postoperative morbidity after hepatic resection in patients with hepatocellular carcinoma (HCC).METHODS: One hundred forty-six patients who underwent hepatic resection for HCC were...

Cite
Itoh S, Yoshizumi T, Shirabe K, et al. Functional remnant liver assessment predicts liver-related morbidity after hepatic resection in patients with hepatocellular carcinoma. Hepatol Res. 2016;47(5):398-404doi: 10.1111/hepr.12761.
Itoh, S., Yoshizumi, T., Shirabe, K., Kimura, K., Okabe, H., Harimoto, N., Ikegami, T., Uchiyama, H., Nishie, A., & Maehara, Y. (2017). Functional remnant liver assessment predicts liver-related morbidity after hepatic resection in patients with hepatocellular carcinoma. Hepatology research : the official journal of the Japan Society of Hepatology, 47(5), 398-404. https://doi.org/10.1111/hepr.12761
Itoh, Shinji, et al. "Functional remnant liver assessment predicts liver-related morbidity after hepatic resection in patients with hepatocellular carcinoma." Hepatology research : the official journal of the Japan Society of Hepatology vol. 47,5 (2017): 398-404. doi: https://doi.org/10.1111/hepr.12761
Itoh S, Yoshizumi T, Shirabe K, Kimura K, Okabe H, Harimoto N, Ikegami T, Uchiyama H, Nishie A, Maehara Y. Functional remnant liver assessment predicts liver-related morbidity after hepatic resection in patients with hepatocellular carcinoma. Hepatol Res. 2017 Apr;47(5):398-404. doi: 10.1111/hepr.12761. Epub 2016 Sep 12. PMID: 27283504.
Copy Download .nbib Format: NLM
Intermediate-Spin Iron(III) Complexes Having a Redox-Noninnocent Macrocyclic Tetraamido Ligand.

Inorganic chemistry

Kojima T, Ogishima F, Nishibu T, Kotani H, Ishizuka T, Okajima T, Nozawa S, Shiota Y, Yoshizawa K, Ohtsu H, Kawano M, Shiga T, Oshio H.
PMID: 29547281
Inorg Chem. 2018 Aug 20;57(16):9683-9695. doi: 10.1021/acs.inorgchem.8b00037. Epub 2018 Mar 16.

An iron(III) complex having a dibenzotetraethyltetraamido macrocyclic ligand (DTTM

Cite
Kojima T, Ogishima F, Nishibu T, et al. Intermediate-Spin Iron(III) Complexes Having a Redox-Noninnocent Macrocyclic Tetraamido Ligand. Inorg Chem. 2018;57(16):9683-9695doi: 10.1021/acs.inorgchem.8b00037.
Kojima, T., Ogishima, F., Nishibu, T., Kotani, H., Ishizuka, T., Okajima, T., Nozawa, S., Shiota, Y., Yoshizawa, K., Ohtsu, H., Kawano, M., Shiga, T., & Oshio, H. (2018). Intermediate-Spin Iron(III) Complexes Having a Redox-Noninnocent Macrocyclic Tetraamido Ligand. Inorganic chemistry, 57(16), 9683-9695. https://doi.org/10.1021/acs.inorgchem.8b00037
Kojima, Takahiko, et al. "Intermediate-Spin Iron(III) Complexes Having a Redox-Noninnocent Macrocyclic Tetraamido Ligand." Inorganic chemistry vol. 57,16 (2018): 9683-9695. doi: https://doi.org/10.1021/acs.inorgchem.8b00037
Kojima T, Ogishima F, Nishibu T, Kotani H, Ishizuka T, Okajima T, Nozawa S, Shiota Y, Yoshizawa K, Ohtsu H, Kawano M, Shiga T, Oshio H. Intermediate-Spin Iron(III) Complexes Having a Redox-Noninnocent Macrocyclic Tetraamido Ligand. Inorg Chem. 2018 Aug 20;57(16):9683-9695. doi: 10.1021/acs.inorgchem.8b00037. Epub 2018 Mar 16. PMID: 29547281.
Copy Download .nbib Format: NLM
Draft Genome Sequence of Mycobacterium bovis Strain AN5, Used for Production of Purified Protein Derivative.

Genome announcements

Canevari Castelão AB, Nishibe C, Moura A, de Alencar AP, de Azevedo Issa M, Hodon MA, Mota PM, Sales EB, Fonseca Júnior AA, Almeida NF, Araújo FR.
PMID: 24699964
Genome Announc. 2014 Apr 03;2(2). doi: 10.1128/genomeA.00277-14.

Mycobacterium bovis strain AN5 has been used to produce purified protein derivative (PPD) for the intradermal test for bovine tuberculosis since it was introduced in 1948. This work reports the draft genome sequence of M. bovis AN5, which is...

Cite
Canevari Castelão AB, Nishibe C, Moura A, et al. Draft Genome Sequence of Mycobacterium bovis Strain AN5, Used for Production of Purified Protein Derivative. Genome Announc. 2014;2(2)doi: 10.1128/genomeA.00277-14.
Canevari Castelão, A. B., Nishibe, C., Moura, A., de Alencar, A. P., de Azevedo Issa, M., Hodon, M. A., Mota, P. M., Sales, E. B., Fonseca Júnior, A. A., Almeida, N. F., & Araújo, F. R. (2014). Draft Genome Sequence of Mycobacterium bovis Strain AN5, Used for Production of Purified Protein Derivative. Genome announcements, 2(2), . https://doi.org/10.1128/genomeA.00277-14
Canevari Castelão, Ana Beatriz, et al. "Draft Genome Sequence of Mycobacterium bovis Strain AN5, Used for Production of Purified Protein Derivative." Genome announcements vol. 2,2 (2014). doi: https://doi.org/10.1128/genomeA.00277-14
Canevari Castelão AB, Nishibe C, Moura A, de Alencar AP, de Azevedo Issa M, Hodon MA, Mota PM, Sales EB, Fonseca Júnior AA, Almeida NF, Araújo FR. Draft Genome Sequence of Mycobacterium bovis Strain AN5, Used for Production of Purified Protein Derivative. Genome Announc. 2014 Apr 03;2(2). doi: 10.1128/genomeA.00277-14. PMID: 24699964; PMCID: PMC3974946.
Copy Download .nbib Format: NLM
"Click" Incorporation of Radical/Ionic Sites into a Reactive Block Copolymer: A Facile and On-Demand Domain Functionalization Approach toward Organic Resistive Memory.

Macromolecular rapid communications

Suga T, Aoki K, Yashiro T, Nishide H.
PMID: 26583561
Macromol Rapid Commun. 2016 Jan;37(1):53-59. doi: 10.1002/marc.201500492. Epub 2015 Nov 19.

Reversible addition-fragmentation chain transfer polymerization yields reactive block copolymers bearing the pentafluorophenyl ester (PFPA) group, and subsequent Click amidation using 2,2,6,6-tetramethylpiperidine-N-oxyl- and imidazolium-functionalized primary amines produces the corresponding functional block copolymers, leading to installation of statistical radical- and ionic...

Cite
Suga T, Aoki K, Yashiro T, et al. "Click" Incorporation of Radical/Ionic Sites into a Reactive Block Copolymer: A Facile and On-Demand Domain Functionalization Approach toward Organic Resistive Memory. Macromol Rapid Commun. 2015;37(1):53-59doi: 10.1002/marc.201500492.
Suga, T., Aoki, K., Yashiro, T., & Nishide, H. (2016). "Click" Incorporation of Radical/Ionic Sites into a Reactive Block Copolymer: A Facile and On-Demand Domain Functionalization Approach toward Organic Resistive Memory. Macromolecular rapid communications, 37(1), 53-59. https://doi.org/10.1002/marc.201500492
Suga, Takeo, et al. ""Click" Incorporation of Radical/Ionic Sites into a Reactive Block Copolymer: A Facile and On-Demand Domain Functionalization Approach toward Organic Resistive Memory." Macromolecular rapid communications vol. 37,1 (2016): 53-59. doi: https://doi.org/10.1002/marc.201500492
Suga T, Aoki K, Yashiro T, Nishide H. "Click" Incorporation of Radical/Ionic Sites into a Reactive Block Copolymer: A Facile and On-Demand Domain Functionalization Approach toward Organic Resistive Memory. Macromol Rapid Commun. 2016 Jan;37(1):53-59. doi: 10.1002/marc.201500492. Epub 2015 Nov 19. PMID: 26583561.
Copy Download .nbib Format: NLM
Draft Genome Sequence of Mycobacterium bovis 04-303, a Highly Virulent Strain from Argentina.

Genome announcements

Nishibe C, Canevari Castelão AB, Dalla Costa R, Pinto BJ, Varuzza L, Cataldi AA, Bernardelli A, Bigi F, Blanco FC, Zumárraga MJ, Almeida NF, Araújo FR.
PMID: 24285661
Genome Announc. 2013 Nov 27;1(6). doi: 10.1128/genomeA.00931-13.

Mycobacterium bovis strain 04-303 was isolated from a wild boar living in a free-ranging field in Argentina. This work reports the draft genome sequence of this highly virulent strain and the genomic comparison of its major virulence-related genes with...

Cite
Nishibe C, Canevari Castelão AB, Dalla Costa R, et al. Draft Genome Sequence of Mycobacterium bovis 04-303, a Highly Virulent Strain from Argentina. Genome Announc. 2013;1(6)doi: 10.1128/genomeA.00931-13.
Nishibe, C., Canevari Castelão, A. B., Dalla Costa, R., Pinto, B. J., Varuzza, L., Cataldi, A. A., Bernardelli, A., Bigi, F., Blanco, F. C., Zumárraga, M. J., Almeida, N. F., & Araújo, F. R. (2013). Draft Genome Sequence of Mycobacterium bovis 04-303, a Highly Virulent Strain from Argentina. Genome announcements, 1(6), . https://doi.org/10.1128/genomeA.00931-13
Nishibe, Christiane, et al. "Draft Genome Sequence of Mycobacterium bovis 04-303, a Highly Virulent Strain from Argentina." Genome announcements vol. 1,6 (2013). doi: https://doi.org/10.1128/genomeA.00931-13
Nishibe C, Canevari Castelão AB, Dalla Costa R, Pinto BJ, Varuzza L, Cataldi AA, Bernardelli A, Bigi F, Blanco FC, Zumárraga MJ, Almeida NF, Araújo FR. Draft Genome Sequence of Mycobacterium bovis 04-303, a Highly Virulent Strain from Argentina. Genome Announc. 2013 Nov 27;1(6). doi: 10.1128/genomeA.00931-13. PMID: 24285661; PMCID: PMC3869323.
Copy Download .nbib Format: NLM
A Single-Center, Open-Label, Randomized, Parallel-Group Study Assessing the Differences Between an Angiotensin II Receptor Antagonist and an Angiotensin-Converting Enzyme Inhibitor in Hypertensive Patients with Congestive Heart Failure: The Research for Efficacy of Angiotensin II Receptor Antagonist in Hypertensive Patients with Congestive Heart Failure Study.

Current therapeutic research, clinical and experimental

Totsuka N, Awata N, Takahashi K, Yamamura H, Nakamura J, Tsuchikane E, Kobayashi Y, Nishibe A, Terai K.
PMID: 24944358
Curr Ther Res Clin Exp. 2003 Feb;64(2):81-94. doi: 10.1016/S0011-393X(03)00020-1.

BACKGROUND: Angiotensin II receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACEIs) have been used to treat congestive heart failure (CHF). According to a MEDLINE search, however, few studies are available on the clinical differences between ARBs and ACEIs in...

Cite
Totsuka N, Awata N, Takahashi K, et al. A Single-Center, Open-Label, Randomized, Parallel-Group Study Assessing the Differences Between an Angiotensin II Receptor Antagonist and an Angiotensin-Converting Enzyme Inhibitor in Hypertensive Patients with Congestive Heart Failure: The Research for Efficacy of Angiotensin II Receptor Antagonist in Hypertensive Patients with Congestive Heart Failure Study. Curr Ther Res Clin Exp. 2003;64(2):81-94doi: 10.1016/S0011-393X(03)00020-1.
Totsuka, N., Awata, N., Takahashi, K., Yamamura, H., Nakamura, J., Tsuchikane, E., Kobayashi, Y., Nishibe, A., & Terai, K. (2003). A Single-Center, Open-Label, Randomized, Parallel-Group Study Assessing the Differences Between an Angiotensin II Receptor Antagonist and an Angiotensin-Converting Enzyme Inhibitor in Hypertensive Patients with Congestive Heart Failure: The Research for Efficacy of Angiotensin II Receptor Antagonist in Hypertensive Patients with Congestive Heart Failure Study. Current therapeutic research, clinical and experimental, 64(2), 81-94. https://doi.org/10.1016/S0011-393X(03)00020-1
Totsuka, Nobuo, et al. "A Single-Center, Open-Label, Randomized, Parallel-Group Study Assessing the Differences Between an Angiotensin II Receptor Antagonist and an Angiotensin-Converting Enzyme Inhibitor in Hypertensive Patients with Congestive Heart Failure: The Research for Efficacy of Angiotensin II Receptor Antagonist in Hypertensive Patients with Congestive Heart Failure Study." Current therapeutic research, clinical and experimental vol. 64,2 (2003): 81-94. doi: https://doi.org/10.1016/S0011-393X(03)00020-1
Totsuka N, Awata N, Takahashi K, Yamamura H, Nakamura J, Tsuchikane E, Kobayashi Y, Nishibe A, Terai K. A Single-Center, Open-Label, Randomized, Parallel-Group Study Assessing the Differences Between an Angiotensin II Receptor Antagonist and an Angiotensin-Converting Enzyme Inhibitor in Hypertensive Patients with Congestive Heart Failure: The Research for Efficacy of Angiotensin II Receptor Antagonist in Hypertensive Patients with Congestive Heart Failure Study. Curr Ther Res Clin Exp. 2003 Feb;64(2):81-94. doi: 10.1016/S0011-393X(03)00020-1. PMID: 24944358; PMCID: PMC4053004.
Copy Download .nbib Format: NLM
β-Decay Half-Lives of 110 Neutron-Rich Nuclei across the N=82 Shell Gap: Implications for the Mechanism and Universality of the Astrophysical r Process.

Physical review letters

Lorusso G, Nishimura S, Xu ZY, Jungclaus A, Shimizu Y, Simpson GS, Söderström PA, Watanabe H, Browne F, Doornenbal P, Gey G, Jung HS, Meyer B, Sumikama T, Taprogge J, Vajta Z, Wu J, Baba H, Benzoni G, Chae KY, Crespi FC, Fukuda N, Gernhäuser R, Inabe N, Isobe T, Kajino T, Kameda D, Kim GD, Kim YK, Kojouharov I, Kondev FG, Kubo T, Kurz N, Kwon YK, Lane GJ, Li Z, Montaner-Pizá A, Moschner K, Naqvi F, Niikura M, Nishibata H, Odahara A, Orlandi R, Patel Z, Podolyák Z, Sakurai H, Schaffner H, Schury P, Shibagaki S, Steiger K, Suzuki H, Takeda H, Wendt A, Yagi A, Yoshinaga K.
PMID: 26024165
Phys Rev Lett. 2015 May 15;114(19):192501. doi: 10.1103/PhysRevLett.114.192501. Epub 2015 May 11.

The β-decay half-lives of 110 neutron-rich isotopes of the elements from _{37}Rb to _{50}Sn were measured at the Radioactive Isotope Beam Factory. The 40 new half-lives follow robust systematics and highlight the persistence of shell effects. The new data...

Cite
Lorusso G, Nishimura S, Xu ZY, et al. β-Decay Half-Lives of 110 Neutron-Rich Nuclei across the N=82 Shell Gap: Implications for the Mechanism and Universality of the Astrophysical r Process. Phys Rev Lett. 2015;114(19):192501doi: 10.1103/PhysRevLett.114.192501.
Lorusso, G., Nishimura, S., Xu, Z. Y., Jungclaus, A., Shimizu, Y., Simpson, G. S., Söderström, P. A., Watanabe, H., Browne, F., Doornenbal, P., Gey, G., Jung, H. S., Meyer, B., Sumikama, T., Taprogge, J., Vajta, Z., Wu, J., Baba, H., Benzoni, G., Chae, K. Y., Crespi, F. C., Fukuda, N., Gernhäuser, R., Inabe, N., Isobe, T., Kajino, T., Kameda, D., Kim, G. D., Kim, Y. K., Kojouharov, I., Kondev, F. G., Kubo, T., Kurz, N., Kwon, Y. K., Lane, G. J., Li, Z., Montaner-Pizá, A., Moschner, K., Naqvi, F., Niikura, M., Nishibata, H., Odahara, A., Orlandi, R., Patel, Z., Podolyák, Z., Sakurai, H., Schaffner, H., Schury, P., Shibagaki, S., Steiger, K., Suzuki, H., Takeda, H., Wendt, A., Yagi, A., & Yoshinaga, K. (2015). β-Decay Half-Lives of 110 Neutron-Rich Nuclei across the N=82 Shell Gap: Implications for the Mechanism and Universality of the Astrophysical r Process. Physical review letters, 114(19), 192501. https://doi.org/10.1103/PhysRevLett.114.192501
Lorusso, G, et al. "β-Decay Half-Lives of 110 Neutron-Rich Nuclei across the N=82 Shell Gap: Implications for the Mechanism and Universality of the Astrophysical r Process." Physical review letters vol. 114,19 (2015): 192501. doi: https://doi.org/10.1103/PhysRevLett.114.192501
Lorusso G, Nishimura S, Xu ZY, Jungclaus A, Shimizu Y, Simpson GS, Söderström PA, Watanabe H, Browne F, Doornenbal P, Gey G, Jung HS, Meyer B, Sumikama T, Taprogge J, Vajta Z, Wu J, Baba H, Benzoni G, Chae KY, Crespi FC, Fukuda N, Gernhäuser R, Inabe N, Isobe T, Kajino T, Kameda D, Kim GD, Kim YK, Kojouharov I, Kondev FG, Kubo T, Kurz N, Kwon YK, Lane GJ, Li Z, Montaner-Pizá A, Moschner K, Naqvi F, Niikura M, Nishibata H, Odahara A, Orlandi R, Patel Z, Podolyák Z, Sakurai H, Schaffner H, Schury P, Shibagaki S, Steiger K, Suzuki H, Takeda H, Wendt A, Yagi A, Yoshinaga K. β-Decay Half-Lives of 110 Neutron-Rich Nuclei across the N=82 Shell Gap: Implications for the Mechanism and Universality of the Astrophysical r Process. Phys Rev Lett. 2015 May 15;114(19):192501. doi: 10.1103/PhysRevLett.114.192501. Epub 2015 May 11. PMID: 26024165.
Copy Download .nbib Format: NLM
Combined effects of soy isoflavones and milk basic protein on bone mineral density in hind-limb unloaded mice.

Journal of clinical biochemistry and nutrition

Matsumoto Y, Tousen Y, Nishide Y, Tadaishi M, Kato K, Ishimi Y.
PMID: 27013781
J Clin Biochem Nutr. 2016 Mar;58(2):141-5. doi: 10.3164/jcbn.14-137. Epub 2016 Jan 22.

We examined whether the combination of isoflavone and milk basic protein both are reported to be effective for bone metabolism, prevents bone loss induced by skeletal hind-limb unloading in mice. Female ddY strain mice, aged 8 weeks, were divided...

Cite
Matsumoto Y, Tousen Y, Nishide Y, et al. Combined effects of soy isoflavones and milk basic protein on bone mineral density in hind-limb unloaded mice. J Clin Biochem Nutr. 2016;58(2):141-5doi: 10.3164/jcbn.14-137.
Matsumoto, Y., Tousen, Y., Nishide, Y., Tadaishi, M., Kato, K., & Ishimi, Y. (2016). Combined effects of soy isoflavones and milk basic protein on bone mineral density in hind-limb unloaded mice. Journal of clinical biochemistry and nutrition, 58(2), 141-5. https://doi.org/10.3164/jcbn.14-137
Matsumoto, Yu, et al. "Combined effects of soy isoflavones and milk basic protein on bone mineral density in hind-limb unloaded mice." Journal of clinical biochemistry and nutrition vol. 58,2 (2016): 141-5. doi: https://doi.org/10.3164/jcbn.14-137
Matsumoto Y, Tousen Y, Nishide Y, Tadaishi M, Kato K, Ishimi Y. Combined effects of soy isoflavones and milk basic protein on bone mineral density in hind-limb unloaded mice. J Clin Biochem Nutr. 2016 Mar;58(2):141-5. doi: 10.3164/jcbn.14-137. Epub 2016 Jan 22. PMID: 27013781; PMCID: PMC4788396.
Copy Download .nbib Format: NLM
Response of eyes with age-related macular degeneration to anti-VEGF drugs and implications for therapy planning.

Clinical ophthalmology (Auckland, N.Z.)

Miyamoto N, Mandai M, Kojima H, Kameda T, Shimozono M, Nishida A, Kurimoto Y.
PMID: 28496299
Clin Ophthalmol. 2017 Apr 28;11:809-816. doi: 10.2147/OPTH.S133332. eCollection 2017.

PURPOSE: To evaluate the response to and dependence on aflibercept or ranibizumab in patients with age-related macular degeneration (AMD).METHODS: We retrospectively reviewed AMD patients who received induction therapy with aflibercept or ranibizumab for the following parameters: whether complete resolution...

Cite
Miyamoto N, Mandai M, Kojima H, et al. Response of eyes with age-related macular degeneration to anti-VEGF drugs and implications for therapy planning. Clin Ophthalmol. 2017;11:809-816doi: 10.2147/OPTH.S133332.
Miyamoto, N., Mandai, M., Kojima, H., Kameda, T., Shimozono, M., Nishida, A., & Kurimoto, Y. (2017). Response of eyes with age-related macular degeneration to anti-VEGF drugs and implications for therapy planning. Clinical ophthalmology (Auckland, N.Z.), 11809-816. https://doi.org/10.2147/OPTH.S133332
Miyamoto, Noriko, et al. "Response of eyes with age-related macular degeneration to anti-VEGF drugs and implications for therapy planning." Clinical ophthalmology (Auckland, N.Z.) vol. 11 (2017): 809-816. doi: https://doi.org/10.2147/OPTH.S133332
Miyamoto N, Mandai M, Kojima H, Kameda T, Shimozono M, Nishida A, Kurimoto Y. Response of eyes with age-related macular degeneration to anti-VEGF drugs and implications for therapy planning. Clin Ophthalmol. 2017 Apr 28;11:809-816. doi: 10.2147/OPTH.S133332. eCollection 2017. PMID: 28496299; PMCID: PMC5417657.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 421 entries